Log In
BCIQ
Print this Print this
 

IMM60

  Manage Alerts
Collapse Summary General Information
Company iOx Therapeutics
DescriptionSynthetic lipid compound that activates invariant natural killer T-cells
Molecular Target Natural killer T cells
Mechanism of Action 
Therapeutic ModalityMacromolecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/22/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today